PL2027152T3 - Fragmenty peptydów do indukowania syntezy białek macierzy zewnątrzkomórkowej - Google Patents
Fragmenty peptydów do indukowania syntezy białek macierzy zewnątrzkomórkowejInfo
- Publication number
- PL2027152T3 PL2027152T3 PL07796001T PL07796001T PL2027152T3 PL 2027152 T3 PL2027152 T3 PL 2027152T3 PL 07796001 T PL07796001 T PL 07796001T PL 07796001 T PL07796001 T PL 07796001T PL 2027152 T3 PL2027152 T3 PL 2027152T3
- Authority
- PL
- Poland
- Prior art keywords
- seq
- extracellular matrix
- peptide fragments
- matrix proteins
- pkgp
- Prior art date
Links
- 230000001939 inductive effect Effects 0.000 title abstract 2
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 title 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 title 1
- 108010033276 Peptide Fragments Proteins 0.000 title 1
- 102000007079 Peptide Fragments Human genes 0.000 title 1
- 230000015572 biosynthetic process Effects 0.000 title 1
- 238000003786 synthesis reaction Methods 0.000 title 1
- 239000003814 drug Substances 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 102000008186 Collagen Human genes 0.000 abstract 1
- 108010035532 Collagen Proteins 0.000 abstract 1
- 229920001436 collagen Polymers 0.000 abstract 1
- 230000037319 collagen production Effects 0.000 abstract 1
- 239000002537 cosmetic Substances 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 238000000338 in vitro Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000004936 stimulating effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
- C07K5/1008—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/07—Tetrapeptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Toxicology (AREA)
- Birds (AREA)
- Zoology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Immunology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US81328406P | 2006-06-13 | 2006-06-13 | |
| EP07796001A EP2027152B1 (en) | 2006-06-13 | 2007-06-12 | Peptide fragments for inducing synthesis of extracellular matrix proteins |
| PCT/US2007/013748 WO2007146269A2 (en) | 2006-06-13 | 2007-06-12 | Peptide fragments for inducing synthesis of extracellular matrix proteins |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2027152T3 true PL2027152T3 (pl) | 2012-04-30 |
Family
ID=38664422
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL11175263T PL2409988T3 (pl) | 2006-06-13 | 2007-06-12 | Fragmenty peptydów do indukcji syntezy białek macierzy zewnątrzkomórkowej |
| PL07796001T PL2027152T3 (pl) | 2006-06-13 | 2007-06-12 | Fragmenty peptydów do indukowania syntezy białek macierzy zewnątrzkomórkowej |
| PL15188894T PL3002294T3 (pl) | 2006-06-13 | 2007-06-12 | Fragmenty peptydowe do indukowania syntezy białek macierzy zewnątrzkomórkowej |
| PL11175264T PL2402369T3 (pl) | 2006-06-13 | 2007-06-12 | Fragmenty peptydów do indukowania syntezy białek macierzy zewnątrzkomórkowej |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL11175263T PL2409988T3 (pl) | 2006-06-13 | 2007-06-12 | Fragmenty peptydów do indukcji syntezy białek macierzy zewnątrzkomórkowej |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL15188894T PL3002294T3 (pl) | 2006-06-13 | 2007-06-12 | Fragmenty peptydowe do indukowania syntezy białek macierzy zewnątrzkomórkowej |
| PL11175264T PL2402369T3 (pl) | 2006-06-13 | 2007-06-12 | Fragmenty peptydów do indukowania syntezy białek macierzy zewnątrzkomórkowej |
Country Status (19)
| Country | Link |
|---|---|
| US (5) | US8110658B2 (pl) |
| EP (5) | EP2402369B1 (pl) |
| JP (2) | JP5535620B2 (pl) |
| CN (2) | CN101472944B (pl) |
| AT (1) | ATE533785T1 (pl) |
| AU (1) | AU2007258387B2 (pl) |
| BR (2) | BR122018002612B8 (pl) |
| CA (4) | CA2835369C (pl) |
| CY (1) | CY1112241T1 (pl) |
| DK (3) | DK2409988T3 (pl) |
| ES (4) | ES2545219T3 (pl) |
| HK (1) | HK1210791A1 (pl) |
| HU (2) | HUE027273T2 (pl) |
| MX (2) | MX361694B (pl) |
| PL (4) | PL2409988T3 (pl) |
| PT (2) | PT2409988E (pl) |
| RU (2) | RU2441877C2 (pl) |
| SI (2) | SI2027152T1 (pl) |
| WO (1) | WO2007146269A2 (pl) |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2835369C (en) * | 2006-06-13 | 2017-01-31 | Helix Biomedix Inc. | Peptide fragments for inducing synthesis of extracellular matrix proteins |
| PL2065029T3 (pl) * | 2007-11-30 | 2013-09-30 | Evonik Degussa Gmbh | Kompozycja do higieny osobistej i kosmetyczna, zawierająca tetrapeptydy z motywami GX1X2G, PX1X2P lub PX1X2K |
| WO2009111471A2 (en) * | 2008-03-03 | 2009-09-11 | Henry Ford Health System | Collagen-derived peptide as biomarker, therapeutic agent and target |
| RU2482127C2 (ru) * | 2008-12-30 | 2013-05-20 | Гкл-Биотек Аг | Комбинация пептидов |
| WO2011044443A2 (en) * | 2009-10-09 | 2011-04-14 | University Of Pittsburgh-Of The Commonwealth System Of Higher Education | Matricryptic ecm peptides for tissue reconstruction |
| WO2014004719A2 (en) | 2012-06-26 | 2014-01-03 | Worcester Polytechnic Institute | Matrix scaffold with antimicrobial activity |
| DK2956155T3 (en) * | 2013-02-14 | 2017-07-31 | Helix Biomedix Inc | Short bioactive peptides to promote wound healing |
| MX360649B (es) | 2013-03-13 | 2018-11-12 | Anteis Sa | Péptidos para el rejuvenecimiento de la piel y métodos de uso de los mismos. |
| US10364451B2 (en) | 2013-05-30 | 2019-07-30 | Duke University | Polymer conjugates having reduced antigenicity and methods of using the same |
| US10392611B2 (en) | 2013-05-30 | 2019-08-27 | Duke University | Polymer conjugates having reduced antigenicity and methods of using the same |
| DK3007716T3 (en) | 2013-06-14 | 2017-07-31 | Helix Biomedix Inc | TETRAPEPTIDES DERIVED BY HUMAN C-X-C CHEMOKINES USED FOR TREATING DIFFERENT SKIN DISORDERS |
| US10385115B2 (en) | 2015-03-26 | 2019-08-20 | Duke University | Fibronectin type III domain-based fusion proteins |
| CA2994279A1 (en) | 2015-08-04 | 2017-02-09 | Duke University | Genetically encoded intrinsically disordered stealth polymers for delivery and methods of using same |
| KR101916522B1 (ko) | 2015-09-25 | 2018-11-08 | 경상대학교산학협력단 | 굴 가수분해물의 제조방법 및 이로부터 분리된 펩타이드 |
| US11752213B2 (en) | 2015-12-21 | 2023-09-12 | Duke University | Surfaces having reduced non-specific binding and antigenicity |
| WO2017210476A1 (en) | 2016-06-01 | 2017-12-07 | Duke University | Nonfouling biosensors |
| WO2018053201A1 (en) * | 2016-09-14 | 2018-03-22 | Duke University | Triblock polypeptide-based nanoparticles for the delivery of hydrophilic drugs |
| JP2020500150A (ja) | 2016-09-23 | 2020-01-09 | デューク ユニバーシティ | 下限臨界溶液温度挙動を有する非反復かつ非構造的ポリペプチド |
| US11648200B2 (en) | 2017-01-12 | 2023-05-16 | Duke University | Genetically encoded lipid-polypeptide hybrid biomaterials that exhibit temperature triggered hierarchical self-assembly |
| JP6489487B2 (ja) * | 2017-01-20 | 2019-03-27 | 富比積生物科技股▲分▼有限公司 | テトラペプチド−３ ｇｅｋｇまたはペンタペプチド−３ ｇｅｋｇｆにより変形性関節症を治療するための新規用途 |
| JP6489486B2 (ja) * | 2017-01-20 | 2019-03-27 | 富比積生物科技股▲分▼有限公司 | ペンタペプチド／ヘキサペプチドにより変形性関節症を治療するための新規用途 |
| WO2018213320A1 (en) | 2017-05-15 | 2018-11-22 | Duke University | Recombinant production of hybrid lipid-biopolymer materials that self-assemble and encapsulate agents |
| US11680083B2 (en) | 2017-06-30 | 2023-06-20 | Duke University | Order and disorder as a design principle for stimuli-responsive biopolymer networks |
| WO2019147954A1 (en) | 2018-01-26 | 2019-08-01 | Duke University | Albumin binding peptide-drug (aibiped) conjugates and methods of making and using same |
| US12257308B2 (en) | 2018-04-30 | 2025-03-25 | Duke University | Stimuli-responsive PEG-like polymer-based drug delivery platform |
| US11649275B2 (en) | 2018-08-02 | 2023-05-16 | Duke University | Dual agonist fusion proteins |
| US11512314B2 (en) | 2019-07-12 | 2022-11-29 | Duke University | Amphiphilic polynucleotides |
| EP4000595A1 (en) * | 2020-11-17 | 2022-05-25 | The Boots Company plc | Tetrapeptide and compositions comprising tetrapeptides |
| EP4000597A1 (en) * | 2020-11-17 | 2022-05-25 | The Boots Company plc | Tetrapeptide and compositions comprising tetrapeptides |
| EP4000596A1 (en) * | 2020-11-17 | 2022-05-25 | The Boots Company plc | Tetrapeptide and compositions comprising tetrapeptides |
| EP4000598A1 (en) * | 2020-11-17 | 2022-05-25 | The Boots Company plc | Tetrapeptide and compositions comprising tetrapeptides |
| EP4140473A1 (en) * | 2021-08-27 | 2023-03-01 | The Boots Company plc | Cosmetic compositions |
| CN115990240A (zh) * | 2021-10-20 | 2023-04-21 | 富比积生物科技股份有限公司 | 寡肽在治疗牙龈发炎、牙龈萎缩及修复口腔黏膜中的用途 |
| CN114437238B (zh) * | 2022-01-26 | 2024-03-26 | 浙江工业大学 | 胶原蛋白肽-牛乳铁蛋白肽融合蛋白、基因及其表达方法 |
| CN115894615A (zh) * | 2022-10-19 | 2023-04-04 | 上海高科生物工程有限公司 | 一种抗皮肤衰老的五肽衍生肽段ys及其应用 |
| CN116375847B (zh) * | 2022-10-26 | 2025-06-13 | 江苏创健医疗科技股份有限公司 | 酵母重组xvii型人源化胶原蛋白及其制备方法 |
Family Cites Families (53)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU466760B2 (en) * | 1972-03-14 | 1975-11-06 | Takeda Chemical Industries Ltd. | Process for producing peptide |
| US5064430A (en) * | 1985-10-31 | 1991-11-12 | Uab Research Foundation | Polynonapeptide bioelastomers having an increased elastic modulus |
| JP2573006B2 (ja) * | 1987-12-17 | 1997-01-16 | 富士薬品工業株式会社 | 新規なヒドロキサム酸誘導体 |
| DE68918388T2 (de) | 1988-04-21 | 1995-03-02 | Uab Research Foundation | Bioelastomer ohne adhäsionseigenschaft zum einsatz am wundort. |
| EP1004595B1 (en) | 1989-04-10 | 2003-06-18 | Helix BioMedix, Inc. | Lytic and proliferative peptides and their use as pharmaceutic and phytopharmaceutic agents |
| US5679770A (en) * | 1991-11-08 | 1997-10-21 | Mochida Pharmaceutical Co., Ltd. | Polypeptide, DNA fragment encoding the same, drug composition containing the same and process for producing the same |
| JP3100005B2 (ja) * | 1992-07-28 | 2000-10-16 | 雪印乳業株式会社 | ヒト免疫不全ウィルス感染・増殖抑制剤 |
| US6132976A (en) * | 1992-12-04 | 2000-10-17 | Shriners Hospitals For Children | Immunoassays for the measurement of collagen denaturation and cleavage in cartilage |
| IL104954A (en) * | 1993-03-04 | 2006-08-01 | Yissum Res Dev Co | Use of osteogenic oligopeptides in the preparation of pharmaceutical compositions for the treatment of bone diseases and some such novel oligopeptides, pharmaceutical compositions containing them and their preparation |
| US5561107A (en) | 1993-06-04 | 1996-10-01 | Demeter Biotechnologies, Ltd. | Method of enhancing wound healing by stimulating fibroblast and keratinocyte growth in vivo, utilizing amphipathic peptides |
| JPH07227281A (ja) * | 1994-02-15 | 1995-08-29 | Agency Of Ind Science & Technol | ペプチダーゼ及びその製造法 |
| US5763576A (en) * | 1995-10-06 | 1998-06-09 | Georgia Tech Research Corp. | Tetrapeptide α-ketoamides |
| US6159940A (en) * | 1996-02-28 | 2000-12-12 | Immunotech Developments Inc. | Method for modulating hemopoiesis |
| DE19651099A1 (de) * | 1996-12-09 | 1998-06-10 | Consortium Elektrochem Ind | Mehrkomponentensystem zum Verändern, Abbau oder Bleichen von Lignin, ligninhaltigen Materialien oder ähnlichen Stoffen sowie Verfahren zu seiner Anwendung |
| EP1074620A1 (en) * | 1999-08-06 | 2001-02-07 | HyGene AG | Monomeric protein of the TGF-beta family |
| EP0858808B1 (en) * | 1997-01-17 | 2003-04-02 | Johnson & Johnson Medical Ltd. | Peptides for use in wound treatment |
| US6639050B1 (en) * | 1997-07-21 | 2003-10-28 | Ohio University | Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins |
| GB2341182A (en) * | 1998-09-01 | 2000-03-08 | Yamanouchi Uk Ltd | Protein comprising amino acid sequences having SH3 domain binding activity and nuclear localisation activity |
| US6747135B1 (en) * | 1998-10-16 | 2004-06-08 | The Board Of Trustees For The Leland Stanford Junior University | Fluorescent dye binding peptides |
| US6492326B1 (en) * | 1999-04-19 | 2002-12-10 | The Procter & Gamble Company | Skin care compositions containing combination of skin care actives |
| CA2276542C (en) | 1999-06-28 | 2013-07-30 | Vladislav I. Deigin | Novel peptide, a method for its preparation and a pharmaceutical composition containing the peptide |
| CN1280983A (zh) * | 1999-07-16 | 2001-01-24 | 王革 | 白细胞介素－11的衍生物及其制备方法 |
| US6627785B1 (en) * | 2000-02-29 | 2003-09-30 | Virginia Commwealth University | Wound dressings with protease-lowering activity |
| AU2001255448A1 (en) * | 2000-04-17 | 2001-10-30 | Stephen B. Liggett | Alpha-2 adrenergic receptor polymorphisms |
| US20030166510A1 (en) * | 2000-10-11 | 2003-09-04 | Pickart Loren R. | Methods and compositions for increasing skin remodeling |
| GB0029777D0 (en) * | 2000-12-06 | 2001-01-17 | Regen Therapeutics Plc | Peptides |
| WO2002079408A2 (en) | 2001-03-28 | 2002-10-10 | Helix Biomedix, Inc. | Short bioactive peptides and methods for their use |
| US7186693B2 (en) * | 2001-08-16 | 2007-03-06 | Kimberly - Clark Worldwide, Inc. | Metalloproteinase inhibitors for wound healing |
| US7041506B2 (en) * | 2001-11-19 | 2006-05-09 | Becton Dickinson And Company | Peptides promoting cell adherence, growth and secretion |
| AU2002341904A1 (en) * | 2001-11-28 | 2003-06-10 | Becton, Dickinson And Company | Peptides with growth inhibitory action |
| US20040009911A1 (en) * | 2002-01-31 | 2004-01-15 | Irm, Llc | Hepsin substrates and prodrugs |
| US7491691B2 (en) * | 2002-05-03 | 2009-02-17 | Sindrey Dennis R | Connective tissue stimulating peptides |
| CA2498329A1 (en) * | 2002-09-09 | 2004-03-18 | University Of Cincinnati | Methods of cardiovascular disease assessment in an individual |
| US7541440B2 (en) * | 2002-09-30 | 2009-06-02 | Immunomedics, Inc. | Chimeric, human and humanized anti-granulocyte antibodies and methods of use |
| TWI256893B (en) * | 2003-03-25 | 2006-06-21 | Fancl Corp | Composition for promoting production of type I collagen and/or elastin |
| DE10339180A1 (de) * | 2003-08-21 | 2005-03-24 | Deutsche Gelatine-Fabriken Stoess Ag | Kollagenhydrolysat |
| US7638318B2 (en) | 2003-09-26 | 2009-12-29 | Norvartis Ag | Seneca Valley virus based compositions and methods for treating disease |
| WO2005048968A1 (en) | 2003-11-17 | 2005-06-02 | Sederma | Compositions containing mixtures of tetrapeptides and tripeptides |
| JP2005245285A (ja) * | 2004-03-03 | 2005-09-15 | National Institute Of Advanced Industrial & Technology | コラーゲン分解物の製造方法 |
| DE102005000868A1 (de) * | 2004-10-15 | 2006-04-20 | Henkel Kgaa | Zusammensetzungen mit Inhibitoren der Prostaglandin- und/oder Leukotrien-Synthese in Kombination mit Stimulatoren der Freisetzung kutaner Neuromediatoren |
| DE102004050563A1 (de) * | 2004-10-15 | 2006-04-20 | Henkel Kgaa | Kosmetische und der dermatologische Zusammensetzungen mit Wirkstoffen für einen verbesserten Hautkomfort |
| DE102004055541A1 (de) * | 2004-11-17 | 2006-05-18 | Henkel Kgaa | Kosmetische und dermatologische Zusammensetzungen zur Behandlung reifer Haut |
| DE202004012807U1 (de) * | 2004-08-13 | 2004-10-21 | Henkel Kgaa | Kosmetische und dermatologische Zusammensetzungen mit DNA-Reparaturenzymen und Oligopeptiden |
| WO2006028993A2 (en) * | 2004-09-02 | 2006-03-16 | Vanderbilt University | Assessment of cancer susceptibility to molecular targeted therapy by use of recombinant peptides |
| CA2583113C (en) * | 2004-10-05 | 2015-11-10 | Diversa Corporation | Compositions comprising an antigen and a promiscuous t-cell epitope |
| ES2426441T3 (es) * | 2004-10-18 | 2013-10-23 | Basf Beauty Care Solutions France S.A.S. | Oligopéptidos y su uso en cosméticos |
| WO2006048339A2 (en) * | 2004-11-04 | 2006-05-11 | L'oréal | Cosmetic composition comrising an active agent and a urea compound |
| US20070224150A1 (en) * | 2005-03-24 | 2007-09-27 | Yongji Chung | Growth factor for hair and skin treatment |
| FR2884418B1 (fr) * | 2005-04-15 | 2008-11-21 | Soc Extraction Principes Actif | Utilisation d'un peptide comme principe actif amincissant |
| SG163567A1 (en) * | 2005-07-05 | 2010-08-30 | Biotempt Bv | Treatment of tumors |
| DE102005063062A1 (de) * | 2005-12-29 | 2007-07-05 | Henkel Kgaa | Synergistische Proteinhydrolysat-Kombinationen zur Behandlung reifer Haut |
| US7807625B2 (en) * | 2006-01-18 | 2010-10-05 | Grant Industries, Inc | Anti-wrinkle composition |
| CA2835369C (en) * | 2006-06-13 | 2017-01-31 | Helix Biomedix Inc. | Peptide fragments for inducing synthesis of extracellular matrix proteins |
-
2007
- 2007-06-12 CA CA2835369A patent/CA2835369C/en active Active
- 2007-06-12 EP EP11175264.8A patent/EP2402369B1/en active Active
- 2007-06-12 EP EP15188894.8A patent/EP3002294B8/en active Active
- 2007-06-12 CN CN200780021825.XA patent/CN101472944B/zh active Active
- 2007-06-12 PL PL11175263T patent/PL2409988T3/pl unknown
- 2007-06-12 SI SI200730836T patent/SI2027152T1/sl unknown
- 2007-06-12 CN CN201410160286.XA patent/CN104017071B/zh active Active
- 2007-06-12 HU HUE11175263A patent/HUE027273T2/en unknown
- 2007-06-12 ES ES11175263.0T patent/ES2545219T3/es active Active
- 2007-06-12 EP EP15167681.4A patent/EP2940042A3/en not_active Withdrawn
- 2007-06-12 ES ES07796001T patent/ES2375413T3/es active Active
- 2007-06-12 HU HUE11175264A patent/HUE026698T2/en unknown
- 2007-06-12 AT AT07796001T patent/ATE533785T1/de active
- 2007-06-12 AU AU2007258387A patent/AU2007258387B2/en active Active
- 2007-06-12 ES ES15188894.8T patent/ES2680022T3/es active Active
- 2007-06-12 RU RU2009100884/10A patent/RU2441877C2/ru active
- 2007-06-12 BR BR122018002612A patent/BR122018002612B8/pt active IP Right Grant
- 2007-06-12 PT PT111752630T patent/PT2409988E/pt unknown
- 2007-06-12 WO PCT/US2007/013748 patent/WO2007146269A2/en not_active Ceased
- 2007-06-12 CA CA2655116A patent/CA2655116C/en active Active
- 2007-06-12 CA CA2947353A patent/CA2947353A1/en not_active Abandoned
- 2007-06-12 MX MX2012002629A patent/MX361694B/es unknown
- 2007-06-12 DK DK11175263.0T patent/DK2409988T3/en active
- 2007-06-12 CA CA2947349A patent/CA2947349A1/en not_active Abandoned
- 2007-06-12 DK DK11175264.8T patent/DK2402369T3/en active
- 2007-06-12 MX MX2008016011A patent/MX2008016011A/es active IP Right Grant
- 2007-06-12 PL PL07796001T patent/PL2027152T3/pl unknown
- 2007-06-12 EP EP11175263.0A patent/EP2409988B1/en active Active
- 2007-06-12 PL PL15188894T patent/PL3002294T3/pl unknown
- 2007-06-12 JP JP2009515450A patent/JP5535620B2/ja active Active
- 2007-06-12 PT PT111752648T patent/PT2402369E/pt unknown
- 2007-06-12 ES ES11175264.8T patent/ES2557402T3/es active Active
- 2007-06-12 BR BRPI0713153A patent/BRPI0713153B8/pt active IP Right Grant
- 2007-06-12 PL PL11175264T patent/PL2402369T3/pl unknown
- 2007-06-12 EP EP07796001A patent/EP2027152B1/en active Active
- 2007-06-12 RU RU2011141572/10A patent/RU2501807C2/ru active
- 2007-06-12 SI SI200731682T patent/SI2409988T1/sl unknown
- 2007-06-12 DK DK07796001.1T patent/DK2027152T3/da active
- 2007-06-12 US US11/811,876 patent/US8110658B2/en active Active
-
2009
- 2009-08-21 HK HK15111547.8A patent/HK1210791A1/en unknown
-
2011
- 2011-12-29 US US13/339,606 patent/US8658764B2/en active Active
-
2012
- 2012-01-16 CY CY20121100042T patent/CY1112241T1/el unknown
-
2013
- 2013-08-07 US US13/961,782 patent/US8962798B2/en active Active
-
2014
- 2014-02-13 JP JP2014025001A patent/JP5844834B2/ja active Active
- 2014-11-03 US US14/531,081 patent/US9447143B2/en not_active Expired - Fee Related
-
2016
- 2016-08-17 US US15/239,708 patent/US10376557B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3002294B8 (en) | Peptide fragments for inducing synthesis of extracellular matrix proteins | |
| EP2520590A3 (en) | Cross-species-specific binding domain | |
| IL163970A0 (en) | Dedifferentiated, programmable stemcells of monocytic origin, and their production and use | |
| BR112012017345A2 (pt) | "composições e métodos de pgl para a produção aumentada de isopreno e outros produtos com 6-fosfogliconolactonase (pgl)" | |
| NZ621196A (en) | Tissue protective peptides and peptide analogs for preventing and treating diseases and disorders associated with tissue damage | |
| MX2009012650A (es) | Secuencias de aminoacido dirigidas contra rank-l y polipeptidos que comprenden lo mismo para el tratamiento de enfermedades y trastornos de huesos. | |
| UA117216C2 (uk) | Пухлиноасоційований пептид та його застосування | |
| JP2009539987A5 (pl) | ||
| NZ597580A (en) | Polypeptides selective for alpha.v.beta.3 integrin conjugated with a variant of human serum albumin (hsa) and pharmaceutical uses thereof | |
| UA100127C2 (ru) | Пептид cdh3 и лекарственное средство, содержащее его | |
| MY148258A (en) | Phenylamino-benzoxazole substituted carboxylic acids, method for their production and use thereof as medicaments | |
| ATE506957T1 (de) | Prophylaktisches/therapeutisches mittel für neurodegenerative erkrankungen | |
| FI20115870A0 (fi) | Neuroprotektiiviset soluihin tunkeutuvat peptidit | |
| NZ589743A (en) | Anxiolytic composition containing alphas1-casein-derived peptides | |
| GB201018125D0 (en) | Peptide | |
| WO2007078633A3 (en) | Bacteriocin inducer peptides | |
| MX2010005597A (es) | Péptidos inmunoreguladores novedosos, composiciones y usos de los mismos. | |
| DE602004019141D1 (de) | Isoleucyl-valyl-threonyl-asparaginyl-threonyl-threonin (ivtntt) enthaltende biologisch wirksame peptide | |
| EA200801077A1 (ru) | Антагонисты взаимодействия pf4 и rantes | |
| Rahman et al. | Unlocking the Therapeutic Potential of Marine Collagen: A Scientific Exploration for Delaying Aging | |
| FR2900407B1 (fr) | Nouveaux polypeptides induisant des cellules dendritiques ainsi que les medicaments et compositions pharmaceutiques contenant de tels polypeptides | |
| UA95456C2 (ru) | Взаимодействие moraxella catarrhalis с эпителиальными клетками, внеклеточными матриксными белками и системой комплемента | |
| WO2010112711A3 (fr) | Peptides eclaircissants activateurs du proteasome et compositions les contenant | |
| UA36367U (ru) | Способ культивирования каллусной ткани первоцвету весеннего (primula veris) | |
| NZ593774A (en) | Systems and methods for identifying Replikin scaffolds and uses of said Replikin scaffolds |